Navigation Links
Renal Denervation Devices Market - Global Industry Analysis, Size, Share, Growth, and Forecast, 2012 - 2021
Date:1/3/2014

DUBLIN, January 3, 2014 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/xdj2p5/renal_denervation) has announced the addition of the "Renal Denervation Devices (Symplicity, EnligHTN, OneShot, V2, Paradise, TIVUS, Bullfrog, Surround Sound, Micro-Infusion, Ultrasound and Radiofrequency) Market - Global Industry Analysis, Size, Share, Growth, and Forecast, 2012 - 2021" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The study comprises of a strategic analysis of the global market for renal denervation devices, and growth forecast for the period from 2012 - 2021. The scope of the report includes competitive analysis of various market segments based on the product, technology and in-depth scrutiny for different regional markets such as North America, Europe, Asia-Pacific and the rest of the world. The Porter's Five Forces analysis included in the report provides an insight into market dynamics and industry competition. The report also offers a PESTLE analysis on the market segments with regards to the future, segregated in different chapters. The report details across from 2012 to 2021 which includes the information of all projected activities in every phase of the report. The market forecast has been separated in three groups of years (2012-2015, 2015-2018 and 2018-2021) to include a separate analysis of each group. The unique analysis in this way covers all current and predicted future activities though this period and highlights key milestones in the progress of this market in the coming years.

This report provides complete insights on the RDN devices market and also analyzes various factors responsible for market growth. These factors determine various existing trends and their impact on market growth. In all, the report includes a holistic analysis of the global renal denervation devices market, and provides an estimate of growth for the period 2012 - 2021, keeping in mind the various factors affecting the market.

This report also analyzes current trends for hypertension treatment methods and advantages of renal denervation systems over other methods which act as a catalyst for the growth in the market. The report provides analysis of the most popular RDN device platforms such as Medtronic's Symplicity, Covidien's OneShot, Boston Scientific's (Vessix Vascular) V2 system, and other emerging devices which will enable stakeholders to map their strategies.

The report also analyzes growth strategies implemented by existing players which will guide emerging players to develop their own strategies and helps existing players to structure their planning process. The report also includes entry barriers to be considered to cater to the exact business opportunities in this market. Additionally, to aid in tactical decision making, the report also includes competitive profiling of leading players, recent developments in the industry and various business strategies adopted by them. This report will help manufacturers, suppliers and distributors in the renal denervation field to plan and implement their roadmap in different market areas such as emerging geographies and new technologies.


Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Executive Summary

Chapter 3 Global Renal Denervation Devices Market Analysis

Chapter 4 Global Renal Denervation Devices Market Analysis, By Technology

Chapter 5 Global Renal Denervation Devices Market Analysis, By Products

Chapter 6 Renal Denervation Market Analysis, By Geography

Chapter 7 Competitive Analysis: Renal Denervation Market


Companies Mentioned:

  • Boston Scientific Corporation
  • CardioSonic
  • Covidien PLC
  • Kona Medical
  • Medtronic Inc.
  • Mercator Medsystems
  • St.Jude Medical

For more information visit http://www.researchandmarkets.com/research/xdj2p5/renal_denervation


Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net

 


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Renal Denervation Devices Market 2012-2016
2. 3SBio to Develop DJ5 for Progressive Renal Failure in ADPKD Patients
3. LX4211 Achieves Positive Results in Type 2 Diabetes Patients with Renal Impairment
4. Novartiss Serelaxin Has the Potential to Fulfill the Most Pertinent Unmet Needs in Acute Heart Failure by Reducing the Rate of Patient Mortality and the Rate of Worsening Renal Function
5. New data about the safety and efficacy of linagliptin in adults with type 2 diabetes who have moderate to severe renal impairment presented at ADA
6. TVA Medical Raises $9.5 Million to Advance Minimally Invasive Therapy for End-Stage Renal Disease
7. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
8. Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients
9. In Pretreated Advanced Renal Cell Carcinoma, Thought Leaders Opinions and Clinical Data Indicate that Tivopath Has Efficacy and Tolerability Advantages Over Currently Used Therapies
10. U.S. Physicians Report Diabetic Nephropathy as the Renal Condition with the Highest Unmet Need for Treatment
11. A Novel Oral Anticoagulant is Planned to be Developed for Patients with Prosthetic Heart Valves or Chronic Renal Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb. 11, 2016 The primary ... and future adoption patterns on the usage of liquid ... the following: - Timeframe of liquid biopsy ... ctDNA, cfDNA and Evs—by organization type - Sample inflow ... types: blood, saliva, stool, serum, and so on. - ...
(Date:2/11/2016)... 11, 2016  Walgreens has committed to provide drug ... Washington, D.C. as part of a ... commended by shareholder advocacy organization As You Sow. ... "Many people hold on to unneeded drugs because they lack ... consequences." --> Conrad MacKerron , Senior Vice ...
(Date:2/11/2016)... Feb. 11, 2016  MiMedx Group, Inc. (NASDAQ: ... amniotic membrane and other birth tissues, human skin and ... and market advanced products and therapies, announced today that ... Global Healthcare Conference in New York ... Michael J. Senken , Chief Financial Officer and ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... February 13, 2016 , ... DDi , a Makro ... list for its expertise in eClinical Solutions. DDi has built its solution competency ... needs of global clients. DDi provides smarter technology for Clinical Development, Regulatory and ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... a new initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop the advanced skills needed ... top students from U.S. universities who will draw from Siemens’ deep knowledge ...
(Date:2/12/2016)... ... , ... Each year, the American Physical Therapy Association (APTA) offers a Combined ... Convention Center. Almost 10,000 physical therapists across the country are expected to attend this ... their chosen field and network with their colleagues. As in years past, HydroWorx ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ThedaCare ... San Francisco General Hospital on April 5-7. The series is a multi-day, multi-workshop ... habits. The workshops cover a broad range of topics, including coaching skills, the ...
(Date:2/12/2016)... ... February 12, 2016 , ... AssureVest Insurance Group, a locally owned ... charity drive that will raise funds earmarked to purchase computers and software for Mrs. ... , “My school is in a low-income area and has more than 60 2nd ...
Breaking Medicine News(10 mins):